These studies demonstrated that dendritic cells transduced with a CPEB4 expression vector exhibited enhanced antitumor function and induced antitumor immune responses in vitro and in vivo, providing great promise for the treatment of cancer, especially glioma, in the future. Here, CPEB4 is linked to central nervous system cancer.